Technology Wanted

Looking for Imaging Technology for the Diagnostic and Clinical Platforms

We are a large pharmaceutical company proactively seeking new partnership opportunities.


As a fortune 500 multinational corporation operating in the healthcare sector, we are looking for certain new technologies to license or acquire. If you have technologies in these areas, we welcome you to get in touch via Tynax. We have the sales channels to effectively bring new healthcare products to market.

We are keenly aware of and continuously review discoveries and developments across the entire drug discovery and development community. To achieve this, our Review and Licensing Committees, each target a specific therapeutic area or technology. This means that we provide a formal review and response for every viable opportunity.

Area of Interest

- Noninvasive and intravascular imaging platforms for plaque composition and vulnerability.

- Imaging-enhancement agents for plaque composition and vulnerability.

- Plaque and/or circulating markets of inflammation, plaque stability, oxidation, endothelial function, plaque composition.

- Preclinical and clincial assays for soluble and plaque markers.

- Access to coronary atheroma, carotid endarterectomy material and necropsy atheroscloerosis.

> Technologies for measuring vascular dynamics (eg. flow, shear stress, vascular compliance).

Not interested in:

- Myocardial imaging platforms.

- Additional sources of lower extremity atheroma.

Patents and Intellectual Property

We will only consider technology covered by a patent.